Hawaiian Eye 2020

In this episode, we bring you pearls and perspectives from Hawaiian Eye 2020.    Ashley Brissette, MD, MSc, FRCSC, considers the importance of testing for inflammation and dry eye before performing cataract surgery :17 Ryan Bleeks, of Sun Ophthalmics, shares an update on Cequa - cyclosporine ophthalmic solution 0.09% - for the treatment of dry eye disease 2:45 Jay S. Pepose, MD, PhD, discusses treatment options for varicella zoster 4:04 Jennifer M. Loh, MD, discusses the impact that sharing a meibomian gland image can have in patient treatment 6:04 Brandon Ayres, MD, examines the use of the FDA-approved epi-off corneal cross-linking procedure 7:16 John P. Berdahl, MD, discusses the benefits of compounded medications that are unique to ophthalmology 10:18 Femida Kherani, MD, shares pearls for incorporating dermal fillers and neuromodulators 12:13 Craig N. Piso, PhD, shares pearls for improving ophthalmic technician performance 13:01 Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses results of the MOST phase 4 trial 14:30 Richard S. Davidson, MD, discusses surgical correction for keratoconus 15:43 Steven D. Vold, MD, discusses the use of Vyzulta -latanoprostene bunod ophthalmic solution 0.024% by Bausch + Lomb 17:00 Thanks for listening 18:45 Disclosures: Ayres reports being a paid consultant to Glaukos. Bleeks is an employee of Sun Ophthalmics. Brissette reports being a paid consultant to Alcon and Zeiss. Loh reports being a paid consultant to Sight Sciences. Mitro is president and COO of Aerie Pharmaceuticals. Vold reports being a paid consultant to Bausch + Lomb. Davidson, Kherani, Pepose and Piso report no relevant financial disclosures.